Business / Finance

RSS

Catasys' total revenues increase 169% to $2.0 million in 2014

Catasys, Inc., provider of proprietary health management services to health insurers and employers, today reported full year 2014 financial results for the period ended December 31, 2014.

1 Apr 2015

Hitachi Aloka Medical becomes exclusive global distributor of iVu Imaging’s SOFIA system

Hitachi Aloka Medical, Ltd. (Headquartered in Tokyo, Japan, President: Mr. Minoru Yoshizumi) and iVu Imaging Corporation announced the signing of an agreement making Hitachi Aloka Medical, Ltd. the exclusive global distributor of iVu’s SOFIA system, an automated whole breast ultrasound scanner designed to enable the earlier detection of breast cancer in women with mammographically dense breasts.

1 Apr 2015

Neurocrine Biosciences, Mitsubishi Tanabe to develop and commercialize NBI-98854 in select Asian markets

Neurocrine Biosciences, Inc. today announced that it has entered into an exclusive collaboration and licensing agreement for the development and commercialization of its VMAT2 inhibitor, NBI-98854, in Japan and other select Asian markets with Mitsubishi Tanabe Pharma Corporation.

1 Apr 2015

ATI Physical Therapy acquires Flexeon Rehabilitation

ATI Physical Therapy today announces the acquisition of Flexeon Rehabilitation, a 16 clinic practice with locations in Chicagoland and Northwest Indiana. ATI is the nation's largest physical therapy practice under one brand, and recently expanded into the state of Nevada with the addition of 12 clinics in the Las Vegas area.

31 Mar 2015

ITOCHU CHEMICAL FRONTIER makes strategic investment in SCILEX Pharmaceuticals

SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced that ITOCHU CHEMICAL FRONTIER Corporation (ICF, Tokyo Japan), a member of ITOCHU Corporation, one of the three leading sogo shosha (general trading companies) in Japan, has made a strategic investment in SCILEX.

31 Mar 2015

IDT supports unique bioengineering public outreach program

To help the general public understand how bioengineering is changing the world for the better, Integrated DNA Technologies (IDT) is supporting a unique public outreach program led by expert plant synthetic biologists at Revolution Bioengineering.

From Integrated DNA Technologies 31 Mar 2015

Aeterna Zentaris inks Material Transfer Agreement with MUSC

Aeterna Zentaris Inc. today announced that it has agreed to transfer its discovery library of roughly 100,000 unique compounds to the South Carolina Center for Therapeutic Discovery & Development (the Center) pursuant to a just concluded Material Transfer Agreement.

31 Mar 2015

China Pharma's revenue decreases 24% to $24.9 million in fiscal year 2014

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the year ended December 31, 2014.

31 Mar 2015

Broad Institute expands collaboration with Bayer to develop new cardiovascular therapies

The Broad Institute of MIT and Harvard have expanded their collaboration with Bayer HealthCare to include cardiovascular genomics and drug discovery. The goal of this new part of the alliance is to leverage insights from human genetics to help create new cardiovascular therapies.

31 Mar 2015

Merck Serono, Intrexon partner to develop and commercialize CAR-T cancer therapies

Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation, today announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies.

30 Mar 2015

Thermo Fisher Scientific to resell Prosolia’s PaperSpray® technology as factory option to its mass spectrometers

Labs performing clinical research and forensic toxicology of dried sample spots can now purchase Thermo Scientific mass spectrometry (MS) systems equipped from the factory with PaperSpray technology, designed to virtually eliminate sample preparation for screening and quantitation of drugs in biological fluid samples.

From Thermo Fisher Scientific Inc. 30 Mar 2015

Biosafe acquires ACTS do Brasil's biosafe-related business

After a successful partnership of 10 years with its local distributor ACTS do Brasil Ltda., effective immediately Biosafe has acquired all ACTS' Biosafe-related business, which has been spun off into a separate operating entity, Biosafe Brasil Distribuidora Ltda. Terms have not been disclosed.

30 Mar 2015

European Commission clears Zimmer's proposed acquisition of Biomet

Zimmer Holdings, Inc. announced today that the European Commission has conditionally cleared Zimmer's proposed acquisition of Biomet, Inc. The EC's clearance is conditioned upon Zimmer entering into agreements with a suitable buyer to divest certain assets comprising the remedy package previously submitted to the EC.

30 Mar 2015

Fujifilm enters into definitive agreement to acquire Cellular Dynamics International

FUJIFILM Holdings Corporation (President: Shigehiro Nakajima) and Cellular Dynamics International, Inc. (CEO: Robert J. Palay), a leading developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today announced that the two companies have entered into a definitive agreement whereby Fujifilm will acquire CDI via an all-cash tender offer to be followed by a second step merger.

30 Mar 2015

HGS acquires majority stake in Colibrium

Hinduja Global Solutions Limited, announced acquisition of majority stake in Colibrium Partners LLC and Colibrium Direct LLC. The acquisition has been made by HGS Colibrium Inc, a US subsidiary of HGS, which would own 89.9% of Colibrium and the balance will be held by the founders. For the year ended 31st December 2014, Colibrium reported revenues of US$ 12.6 mn.

30 Mar 2015

DePuy Synthes inks sales agreement with Radlink to offer real-time image guidance with hip replacement systems

DePuy Synthes Companies has signed an exclusive worldwide sales agreement with Radlink, Inc., an emerging global leader in advanced medical imaging technology, to offer real-time image guidance with its hip replacement systems. The agreement further demonstrates DePuy Synthes Companies’ ongoing commitment to help improve patient outcomes, increase patient satisfaction and reduce costs.

27 Mar 2015

Helsinn, Mundipharma sign distribution and license agreement for anamorelin

Helsinn, a Swiss Group focused on building quality cancer care, and Mundipharma, today announce that they have entered into a distribution and license agreement for the exclusive rights to anamorelin in China, Hong Kong and Macao.

26 Mar 2015

Philips enters into collaboration with Janssen to develop new handheld blood test to support care of patients with neuropsychiatric disorders

Royal Philips today announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V. (Janssen).

From Philips Healthcare 26 Mar 2015

Nanolek, Green Cross sign strategic deal to commercialize biologics in the Russian market

Green Cross, a South Korean biopharmaceutical company, and Nanolek, a Russian pharmaceutical company, today announced that they have entered into a strategic partnership agreement for the commercialisation of Green Cross' biologics in the Russian market.

26 Mar 2015

Brainstorm Cell Therapeutics provides business update, announces financial results for 2014

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced financial results for the three months and year ended December 31, 2014.

26 Mar 2015

Business / Finance

Catasys' total revenues increase 169% to $2.0 million in 2014

Hitachi Aloka Medical becomes exclusive global distributor of iVu Imaging’s SOFIA system

Neurocrine Biosciences, Mitsubishi Tanabe to develop and commercialize NBI-98854 in select Asian markets

ATI Physical Therapy acquires Flexeon Rehabilitation

ITOCHU CHEMICAL FRONTIER makes strategic investment in SCILEX Pharmaceuticals

IDT supports unique bioengineering public outreach program

Aeterna Zentaris inks Material Transfer Agreement with MUSC

China Pharma's revenue decreases 24% to $24.9 million in fiscal year 2014

Broad Institute expands collaboration with Bayer to develop new cardiovascular therapies

Merck Serono, Intrexon partner to develop and commercialize CAR-T cancer therapies

Thermo Fisher Scientific to resell Prosolia’s PaperSpray® technology as factory option to its mass spectrometers

Biosafe acquires ACTS do Brasil's biosafe-related business

European Commission clears Zimmer's proposed acquisition of Biomet

Fujifilm enters into definitive agreement to acquire Cellular Dynamics International

HGS acquires majority stake in Colibrium

DePuy Synthes inks sales agreement with Radlink to offer real-time image guidance with hip replacement systems

Helsinn, Mundipharma sign distribution and license agreement for anamorelin

Philips enters into collaboration with Janssen to develop new handheld blood test to support care of patients with neuropsychiatric disorders

Nanolek, Green Cross sign strategic deal to commercialize biologics in the Russian market

Brainstorm Cell Therapeutics provides business update, announces financial results for 2014

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News